| Year |
Citation |
Score |
| 2024 |
Jensen NM, Fu Y, Betzer C, Li H, Elfarrash S, Shaib AH, Krah D, Vitic Z, Reimer L, Gram H, Buchman V, Denham M, Rizzoli SO, Halliday GM, Jensen PH. MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity. Npj Parkinson's Disease. 10: 227. PMID 39613827 DOI: 10.1038/s41531-024-00841-9 |
0.313 |
|
| 2024 |
Aubrey LD, Ninkina N, Ulamec SM, Abramycheva NY, Vasili E, Devine OM, Wilkinson M, Mackinnon E, Limorenko G, Walko M, Muwanga S, Amadio L, Peters OM, Illarioshkin SN, Outeiro TF, ... ... Buchman VL, et al. Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid. Proceedings of the National Academy of Sciences of the United States of America. 121: e2309700120. PMID 38170745 DOI: 10.1073/pnas.2309700120 |
0.699 |
|
| 2022 |
Vorobyov V, Deev A, Sukhanova I, Morozova O, Oganesyan Z, Chaprov K, Buchman VL. Loss of the Synuclein Family Members Differentially Affects Baseline- and Apomorphine-Associated EEG Determinants in Single-, Double- and Triple-Knockout Mice. Biomedicines. 10. PMID 36551884 DOI: 10.3390/biomedicines10123128 |
0.434 |
|
| 2022 |
Carnazza KE, Komer LE, Xie YX, Pineda A, Briano JA, Gao V, Na Y, Ramlall T, Buchman VL, Eliezer D, Sharma M, Burré J. Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins. Cell Reports. 39: 110675. PMID 35417693 DOI: 10.1016/j.celrep.2022.110675 |
0.312 |
|
| 2021 |
Ninkina N, Millership SJ, Peters OM, Connor-Robson N, Chaprov K, Kopylov AT, Montoya A, Kramer H, Withers DJ, Buchman VL. β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins. The Journal of Biological Chemistry. 101375. PMID 34736896 DOI: 10.1016/j.jbc.2021.101375 |
0.721 |
|
| 2021 |
Chaprov KD, Lysikova EA, Teterina EV, Buchman VL. Kinetics of alpha-synuclein depletion in three brain regions following conditional pan-neuronal inactivation of the encoding gene (Snca) by tamoxifen-induced Cre-recombination in adult mice. Transgenic Research. 30: 867-873. PMID 34590209 DOI: 10.1007/s11248-021-00286-3 |
0.34 |
|
| 2021 |
Chaprov K, Rezvykh A, Funikov S, Ivanova TA, Lysikova EA, Deykin AV, Kukharsky MS, Yu Aksinenko A, Bachurin SO, Ninkina N, Buchman VL. A bioisostere of Dimebon/Latrepirdine delays the onset and slows the progression of pathology in FUS transgenic mice. Cns Neuroscience & Therapeutics. 27: 765-775. PMID 33754495 DOI: 10.1111/cns.13637 |
0.384 |
|
| 2020 |
Hosford PS, Ninkina N, Buchman VL, Smith JC, Marina N, SheikhBahaei S. Synuclein Deficiency Results in Age-Related Respiratory and Cardiovascular Dysfunctions in Mice. Brain Sciences. 10. PMID 32846874 DOI: 10.3390/Brainsci10090583 |
0.405 |
|
| 2020 |
Kukharsky MS, Ninkina NN, An H, Telezhkin V, Wei W, Meritens CR, Cooper-Knock J, Nakagawa S, Hirose T, Buchman VL, Shelkovnikova TA. Long non-coding RNA Neat1 regulates adaptive behavioural response to stress in mice. Translational Psychiatry. 10: 171. PMID 32467583 DOI: 10.1038/S41398-020-0854-2 |
0.338 |
|
| 2020 |
Goloborshcheva VV, Chaprov KD, Teterina EV, Ovchinnikov R, Buchman VL. Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive "low footprint" genetic knockout of alpha-synuclein. Molecular Brain. 13: 75. PMID 32393371 DOI: 10.1186/s13041-020-00613-5 |
0.388 |
|
| 2020 |
Ninkina N, Tarasova TV, Chaprov KD, Roman AY, Kukharsky MS, Kolik LG, Ovchinnikov R, Ustyugov AA, Durnev AD, Buchman VL. Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice. Neurobiology of Aging. 91: 76-87. PMID 32224067 DOI: 10.1016/j.neurobiolaging.2020.02.026 |
0.426 |
|
| 2020 |
Lysikova EA, Funikov S, Rezvykh AP, Chaprov KD, Kukharsky MS, Ustyugov A, Deykin AV, Flyamer IM, Boyle S, Bachurin SO, Ninkina N, Buchman VL. Low Level of Expression of C-Terminally Truncated Human FUS Causes Extensive Changes in the Spinal Cord Transcriptome of Asymptomatic Transgenic Mice. Neurochemical Research. 45: 1168-1179. PMID 32157564 DOI: 10.1007/s11064-020-02999-z |
0.415 |
|
| 2019 |
Lysikova EA, Kukharsky MS, Chaprov KD, Vasilieva NA, Roman AY, Ovchinnikov RK, Deykin AV, Ninkina N, Buchman VL. Behavioural impairments in mice of a novel FUS transgenic line recapitulate features of frontotemporal lobar degeneration. Genes, Brain, and Behavior. 18: e12607. PMID 31437340 DOI: 10.1111/gbb.12607 |
0.461 |
|
| 2016 |
Roman AY, Limorenko G, Ustyugov AA, Tarasova TV, Lysikova EA, Buchman VL, Ninkina N. Generation of mouse lines with conditionally or constitutively inactivated Snca gene and Rosa26-stop-lacZ reporter located in cis on the mouse chromosome 6. Transgenic Research. 26: 301-307. PMID 27838898 DOI: 10.1007/s11248-016-9995-8 |
0.319 |
|
| 2016 |
Connor-Robson N, Peters OM, Millership S, Ninkina N, Buchman VL. Combinational losses of synucleins reveal their differential requirements for compensating age-dependent alterations in motor behavior and dopamine metabolism. Neurobiology of Aging. 46: 107-112. PMID 27614017 DOI: 10.1016/j.neurobiolaging.2016.06.020 |
0.721 |
|
| 2016 |
Fares MB, Maco B, Oueslati A, Rockenstein E, Ninkina N, Buchman VL, Masliah E, Lashuel HA. Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 26839406 DOI: 10.1073/Pnas.1512876113 |
0.44 |
|
| 2015 |
Ninkina N, Connor-Robson N, Ustyugov AA, Tarasova TV, Shelkovnikova TA, Buchman VL. A novel resource for studying function and dysfunction of α-synuclein: mouse lines for modulation of endogenous Snca gene expression. Scientific Reports. 5: 16615. PMID 26564109 DOI: 10.1038/srep16615 |
0.333 |
|
| 2015 |
Robinson HK, Deykin AV, Bronovitsky EV, Ovchinnikov RK, Ustyugov AA, Shelkovnikova TA, Kukharsky MS, Ermolkevich TG, Goldman IL, Sadchikova ER, Kovrazhkina EA, Bachurin SO, Buchman VL, Ninkina NN. Early lethality and neuronal proteinopathy in mice expressing cytoplasm-targeted FUS that lacks the RNA recognition motif. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 16: 402-9. PMID 25991062 DOI: 10.3109/21678421.2015.1040994 |
0.333 |
|
| 2015 |
Kukharsky MS, Quintiero A, Matsumoto T, Matsukawa K, An H, Hashimoto T, Iwatsubo T, Buchman VL, Shelkovnikova TA. Calcium-responsive transactivator (CREST) protein shares a set of structural and functional traits with other proteins associated with amyotrophic lateral sclerosis. Molecular Neurodegeneration. 10: 20. PMID 25888396 DOI: 10.1186/S13024-015-0014-Y |
0.307 |
|
| 2014 |
Peters OM, Shelkovnikova T, Highley JR, Cooper-Knock J, Hortobágyi T, Troakes C, Ninkina N, Buchman VL. Gamma-synuclein pathology in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology. 2: 29-37. PMID 25642432 DOI: 10.1002/acn3.143 |
0.719 |
|
| 2013 |
Shelkovnikova TA, Robinson HK, Troakes C, Ninkina N, Buchman VL. Compromised paraspeckle formation as a pathogenic factor in FUSopathies. Human Molecular Genetics. 23: 2298-312. PMID 24334610 DOI: 10.1093/hmg/ddt622 |
0.374 |
|
| 2013 |
Garcia-Reitboeck P, Anichtchik O, Dalley JW, Ninkina N, Tofaris GK, Buchman VL, Spillantini MG. Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra. Experimental Neurology. 248: 541-5. PMID 23933574 DOI: 10.1016/J.Expneurol.2013.07.015 |
0.429 |
|
| 2013 |
Shelkovnikova TA, Peters OM, Deykin AV, Connor-Robson N, Robinson H, Ustyugov AA, Bachurin SO, Ermolkevich TG, Goldman IL, Sadchikova ER, Kovrazhkina EA, Skvortsova VI, Ling SC, Da Cruz S, Parone PA, ... Buchman VL, et al. Fused in sarcoma (FUS) protein lacking nuclear localization signal (NLS) and major RNA binding motifs triggers proteinopathy and severe motor phenotype in transgenic mice. The Journal of Biological Chemistry. 288: 25266-74. PMID 23867462 DOI: 10.1074/Jbc.M113.492017 |
0.752 |
|
| 2013 |
Peters OM, Shelkovnikova T, Tarasova T, Springe S, Kukharsky MS, Smith GA, Brooks S, Kozin SA, Kotelevtsev Y, Bachurin SO, Ninkina N, Buchman VL. Chronic administration of Dimebon does not ameliorate amyloid-β pathology in 5xFAD transgenic mice. Journal of Alzheimer's Disease : Jad. 36: 589-96. PMID 23645096 DOI: 10.3233/Jad-130071 |
0.706 |
|
| 2013 |
Peters OM, Connor-Robson N, Sokolov VB, Aksinenko AY, Kukharsky MS, Bachurin SO, Ninkina N, Buchman VL. Chronic administration of dimebon ameliorates pathology in TauP301S transgenic mice. Journal of Alzheimer's Disease : Jad. 33: 1041-9. PMID 23099813 DOI: 10.3233/JAD-2012-121732 |
0.691 |
|
| 2012 |
Ninkina N, Peters OM, Connor-Robson N, Lytkina O, Sharfeddin E, Buchman VL. Contrasting effects of α-synuclein and γ-synuclein on the phenotype of cysteine string protein α (CSPα) null mutant mice suggest distinct function of these proteins in neuronal synapses. The Journal of Biological Chemistry. 287: 44471-7. PMID 23129765 DOI: 10.1074/jbc.M112.422402 |
0.725 |
|
| 2012 |
Peters OM, Millership S, Shelkovnikova TA, Soto I, Keeling L, Hann A, Marsh-Armstrong N, Buchman VL, Ninkina N. Selective pattern of motor system damage in gamma-synuclein transgenic mice mirrors the respective pathology in amyotrophic lateral sclerosis. Neurobiology of Disease. 48: 124-31. PMID 22750530 DOI: 10.1016/j.nbd.2012.06.016 |
0.735 |
|
| 2011 |
Bachurin SO, Shelkovnikova TA, Ustyugov AA, Peters O, Khritankova I, Afanasieva MA, Tarasova TV, Alentov II, Buchman VL, Ninkina NN. Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice. Neurotoxicity Research. 22: 33-42. PMID 22179976 DOI: 10.1007/s12640-011-9299-y |
0.751 |
|
| 2011 |
Anwar S, Peters O, Millership S, Ninkina N, Doig N, Connor-Robson N, Threlfell S, Kooner G, Deacon RM, Bannerman DM, Bolam JP, Chandra SS, Cragg SJ, Wade-Martins R, Buchman VL. Functional alterations to the nigrostriatal system in mice lacking all three members of the synuclein family. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 7264-74. PMID 21593311 DOI: 10.1523/Jneurosci.6194-10.2011 |
0.729 |
|
| 2011 |
Shelkovnikova TA, Ustyugov AA, Millership S, Peters O, Anichtchik O, Spillantini MG, Buchman VL, Bachurin SO, Ninkina NN. Dimebon does not ameliorate pathological changes caused by expression of truncated (1-120) human alpha-synuclein in dopaminergic neurons of transgenic mice. Neuro-Degenerative Diseases. 8: 430-7. PMID 21576917 DOI: 10.1159/000324989 |
0.731 |
|
| 2011 |
Guschina I, Millership S, O'Donnell V, Ninkina N, Harwood J, Buchman V. Lipid classes and fatty acid patterns are altered in the brain of γ-synuclein null mutant mice. Lipids. 46: 121-30. PMID 20963507 DOI: 10.1007/s11745-010-3486-0 |
0.347 |
|
| 2010 |
Greten-Harrison B, Polydoro M, Morimoto-Tomita M, Diao L, Williams AM, Nie EH, Makani S, Tian N, Castillo PE, Buchman VL, Chandra SS. αβγ-Synuclein triple knockout mice reveal age-dependent neuronal dysfunction. Proceedings of the National Academy of Sciences of the United States of America. 107: 19573-8. PMID 20974939 DOI: 10.1073/Pnas.1005005107 |
0.502 |
|
| 2010 |
Venda LL, Cragg SJ, Buchman VL, Wade-Martins R. α-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends in Neurosciences. 33: 559-68. PMID 20961626 DOI: 10.1016/j.tins.2010.09.004 |
0.31 |
|
| 2010 |
Burré J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, Südhof TC. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science (New York, N.Y.). 329: 1663-7. PMID 20798282 DOI: 10.1126/Science.1195227 |
0.332 |
|
| 2010 |
Al-Wandi A, Ninkina N, Millership S, Williamson SJ, Jones PA, Buchman VL. Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice. Neurobiology of Aging. 31: 796-804. PMID 19097673 DOI: 10.1016/j.neurobiolaging.2008.11.001 |
0.316 |
|
| 2009 |
Ninkina N, Peters O, Millership S, Salem H, van der Putten H, Buchman VL. Gamma-synucleinopathy: neurodegeneration associated with overexpression of the mouse protein. Human Molecular Genetics. 18: 1779-94. PMID 19246516 DOI: 10.1093/hmg/ddp090 |
0.74 |
|
| 2008 |
Senior SL, Ninkina N, Deacon R, Bannerman D, Buchman VL, Cragg SJ, Wade-Martins R. Increased striatal dopamine release and hyperdopaminergic-like behaviour in mice lacking both alpha-synuclein and gamma-synuclein. The European Journal of Neuroscience. 27: 947-57. PMID 18333965 DOI: 10.1111/j.1460-9568.2008.06055.x |
0.347 |
|
| 2005 |
Papachroni K, Ninkina N, Wanless J, Kalofoutis AT, Gnuchev NV, Buchman VL. Peripheral sensory neurons survive in the absence of alpha- and gamma-synucleins. Journal of Molecular Neuroscience : Mn. 25: 157-64. PMID 15784963 DOI: 10.1385/JMN:25:2:157 |
0.383 |
|
| 2004 |
Robertson DC, Schmidt O, Ninkina N, Jones PA, Sharkey J, Buchman VL. Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice. Journal of Neurochemistry. 89: 1126-36. PMID 15147505 DOI: 10.1111/j.1471-4159.2004.02378.x |
0.33 |
|
| 2004 |
Saha AR, Hill J, Utton MA, Asuni AA, Ackerley S, Grierson AJ, Miller CC, Davies AM, Buchman VL, Anderton BH, Hanger DP. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. Journal of Cell Science. 117: 1017-24. PMID 14996933 DOI: 10.1242/Jcs.00967 |
0.306 |
|
| 2003 |
Ninkina N, Papachroni K, Robertson DC, Schmidt O, Delaney L, O'Neill F, Court F, Rosenthal A, Fleetwood-Walker SM, Davies AM, Buchman VL. Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene. Molecular and Cellular Biology. 23: 8233-45. PMID 14585981 DOI: 10.1128/Mcb.23.22.8233-8245.2003 |
0.399 |
|
| 2003 |
Dev KK, Hofele K, Barbieri S, Buchman VL, van der Putten H. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology. 45: 14-44. PMID 12814657 DOI: 10.1016/S0028-3908(03)00140-0 |
0.399 |
|
| Show low-probability matches. |